A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Päätekijä: | Sorno, Rubina Haque |
---|---|
Muut tekijät: | Khair, Nishat Zareen |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2024
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/23842 |
Samankaltaisia teoksia
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Flora, Sanzida Alam
Julkaistu: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Tekijä: Khan, Muidul Hasan
Julkaistu: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
Tekijä: Ruhee, Noshin Nawer
Julkaistu: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
Tekijä: Raju, Md. Ismail
Julkaistu: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Tekijä: Ratu, Tabassum
Julkaistu: (2024)